Healthcare Equipment and Supplies
Company Overview of Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. develops and commercializes particle-based therapy devices for the selective and precise thermal destruction of solid tumors. The company’s portfolio includes AuroLase therapy that utilizes AuroShell particles/nanoshells, nanorods, and other nanomaterials for particle-based thermal ablation of solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. It also offers research-use-only nanoparticles with specific optical characteristics, such as gold nanoshells and custom production products for medical and commercial applications. The company was incorporated in 2001 and is based in Houston, Texas.
8285 El Rio Street
Houston, TX 77054
Founded in 2001
Key Executives for Nanospectra Biosciences, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
January 27, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Nanospectra Biosciences, Inc., please visit www.nanospectra.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.